Planned clinical trial of glioblast 13
Latest Information Update: 24 Jan 2007
Price :
$35 *
At a glance
- Drugs Glioblast 13 (Primary)
- Indications Colorectal cancer; Glioma; Head and neck cancer; Malignant melanoma
- Focus Adverse reactions
- 24 Jan 2007 Status change
- 24 Jan 2007 New trial record.